MALDI linear TOF mass spectrometry of PEGylated (glyco)proteins
Authors:
- 12 May 2010
- journal article
- research article
- Published by Wiley in Journal of Mass Spectrometry
- Vol. 45 (6) , 612-617
Abstract
PEGylation of proteins is a fast growing field in biotechnology and pharmaceutical sciences owing to its ability to prolong the serum half‐life time of recombinant proteins. Matrix‐assisted laser desorption/ionization time‐of‐flight mass spectrometry (MALDI TOF MS) has been shown to be a powerful tool in the analysis of several PEGylated small proteins. Here we present data obtained with a standard secondary electron multiplier (SEM) and a high mass (HM) detector combined with a MALDI linear TOF MS system for the detection of PEGylated (glyco)proteins in the range of 60–600 kDa. Examples of MALDI TOF MS of small (interferon α2a), middle (human serum albumin (HSA)) and high molecular mass proteins (coagulation factor VIII and von Willebrand factor (vWF), both heavily glycosylated proteins) are presented. The particular challenge for the analysis was the heterogeneity of the (glyco)proteins in the high molecular weight range in combination with additional PEGylation, which even introduced more heterogeneity and was more challenging for interpretation. Nevertheless, the performance of MALDI linear TOF MS with both detector systems in terms molecular weight and heterogeneity determination depending on the m/z range was superior to the other methods. Although the SEM was able to obtain information about protein PEGylation in the mass range up to 100 kDa (e.g. PEGylated HSA), the HM system was crucial for detection of HM ions (e.g. PEGylated recombinant vWF), which was impossible with the standard SEM. Copyright © 2010 John Wiley & Sons, Ltd.Keywords
This publication has 39 references indexed in Scilit:
- Characterization of high molecular weight multimeric states of human haptoglobin and hemoglobin‐based oxygen carriers by high‐mass MALDI MSJournal of Separation Science, 2009
- Defining ‘full‐length’ recombinant factor VIII: a comparative structural analysisHaemophilia, 2006
- Molecular weight determination of ultra‐high mass compounds on a standard matrix‐assisted laser desorption/ionization time‐of‐flight mass spectrometer: PAMAM dendrimer generation 10 and immunoglobulin MRapid Communications in Mass Spectrometry, 2006
- Instrumental Parameters in the MALDI-TOF Mass Spectrometric Analysis of Quaternary Protein StructuresAnalytical Chemistry, 2004
- Optical detection methods for mass spectrometry of macroionsMass Spectrometry Reviews, 2004
- Coagulation factor VIII: structure and stabilityInternational Journal of Pharmaceutics, 2003
- PegylationClinical Pharmacokinetics, 2001
- Matrix-assisted Laser Desorption/Ionization Mass Spectrometry Sample Preparation Techniques Designed for Various Peptide and Protein AnalytesJournal of Mass Spectrometry, 1997
- Improvement of pharmacokinetic, immunological and stability properties of asparaginase by conjugation to linear and branched monomethoxy poly( ethylene glycol)Journal of Controlled Release, 1996
- Biological Regulation of Factor VIII ActivityAnnual Review of Medicine, 1992